Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.

作者: Jorge M. A. Oliveira

DOI: 10.1111/J.1471-4159.2010.06741.X

关键词:

摘要: Polyglutamine expansion mutation in huntingtin causes Huntington's disease (HD). How mutant (mHtt) preferentially kills striatal neurons remains unknown. The link between mitochondrial dysfunction and HD pathogenesis stemmed from postmortem brain data toxin models. Current evidence genetic models, containing mHtt, supports with yet uncertain nature cause. Because mitochondria composition function varies across tissues cell-types, vulnerable may have distinctive features. This review focuses on mHtt the striatum, integrating experimental patients, mice, primary cultures cell-lines. I address (specific deficits) cause (mechanisms linked to mHtt) of dysfunction, considering limitations isolated vs. situ approaches, complications introduced by glia glycolysis cell-culture studies. relegates respiratory chain impairment a late secondary event. Upstream events include defective calcium handling, ATP production trafficking. Also, transcription abnormalities affecting composition, reduced trafficking synapses, direct interference structures enriched neurons, are possible mechanisms which amplifies vulnerability. Insights common neurodegenerative disorders selective vulnerability (Alzheimer's Parkinson's diseases) also addressed.

参考文章(115)
A H V Schapira, Mitochondrial dysfunction in Parkinson's disease Cell Death & Differentiation. ,vol. 14, pp. 1261- 1266 ,(2007) , 10.1038/SJ.CDD.4402160
Aleksey G. Kazantsev, Leslie M. Thompson, Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nature Reviews Drug Discovery. ,vol. 7, pp. 854- 868 ,(2008) , 10.1038/NRD2681
Russell H. Swerdlow, Janice K. Parks, David S. Cassarino, A.Tanner Shilling, James P. Bennett, Madaline B. Harrison, W.Davis Parker, Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. Biochemical and Biophysical Research Communications. ,vol. 261, pp. 701- 704 ,(1999) , 10.1006/BBRC.1999.1095
Alexander V. Panov, Serena Lund, J. Timothy Greenamyre, Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals. Molecular and Cellular Biochemistry. ,vol. 269, pp. 143- 152 ,(2005) , 10.1007/S11010-005-3454-9
Jennifer Q. Kwong, M. Flint Beal, Giovanni Manfredi, The role of mitochondria in inherited neurodegenerative diseases. Journal of Neurochemistry. ,vol. 97, pp. 1659- 1675 ,(2006) , 10.1111/J.1471-4159.2006.03990.X
Ursula Sonnewald, Leif Hertz, Arne Schousboe, Mitochondrial heterogeneity in the brain at the cellular level Journal of Cerebral Blood Flow and Metabolism. ,vol. 18, pp. 231- 237 ,(1998) , 10.1097/00004647-199803000-00001
Paula I. Moreira, Cristina Carvalho, Xiongwei Zhu, Mark A. Smith, George Perry, Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology Biochimica et Biophysica Acta. ,vol. 1802, pp. 2- 10 ,(2010) , 10.1016/J.BBADIS.2009.10.006
Tamara Milakovic, Rodrigo A. Quintanilla, Gail V. W. Johnson, Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells : Functional consequences Journal of Biological Chemistry. ,vol. 281, pp. 34785- 34795 ,(2006) , 10.1074/JBC.M603845200